244 related articles for article (PubMed ID: 2049889)
1. Hemodynamic and neuroendocrine response to acute administration of the phosphodiesterase inhibitor BM14.478 in patients with congestive heart failure.
Rauch B; Zimmermann R; Kapp M; Haass M; Von Molitor S; Smolarz A; Neumann FJ; Kübler W; Dietz R; Tillmanns H
Clin Cardiol; 1991 May; 14(5):386-95. PubMed ID: 2049889
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic and hormonal effects of CI-930, a new phosphodiesterase inhibitor, in severe congestive heart failure.
Murali S; Uretsky BF; Valdes AM; Kolesar JA; Reddy PS
Am J Cardiol; 1987 Jun; 59(15):1356-60. PubMed ID: 3591691
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.
Remme WJ; van der Ent M; Bartels GL; van Schelven D; van Hoogenhuyze DC; Krauss XH; Kruijssen HA; Storm CJ
Cardiovasc Drugs Ther; 1996 May; 10(2):137-44. PubMed ID: 8842505
[TBL] [Abstract][Full Text] [Related]
4. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
5. Acute neurohormonal and hemodynamic response to a new peak III phosphodiesterase inhibitor (ICI 153,110) in patients with chronic heart failure.
Jafri SM; Reddy BR; Budzinski D; Goldberg AD; Pilla A; Levine TB
J Cardiovasc Pharmacol; 1990 Sep; 16(3):360-6. PubMed ID: 1700205
[TBL] [Abstract][Full Text] [Related]
6. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
7. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up.
Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372
[TBL] [Abstract][Full Text] [Related]
8. Contrasting preload-dependent hemodynamic and neurohumoral effects of isomazole, a partial phosphodiesterase inhibitor and calcium sensitizer.
Van der Ent M; Remme WJ; Bartels GL; De Leeuw PW; Van Hoogenhuyze DC; Kruijssen DA
J Card Fail; 1997 Dec; 3(4):277-86. PubMed ID: 9547442
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
[TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
12. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
Petein M; Levine TB; Cohn JN
J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
[TBL] [Abstract][Full Text] [Related]
14. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
Leier CV; Lima JJ; Meiler SE; Unverferth DV
Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
[TBL] [Abstract][Full Text] [Related]
15. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
[TBL] [Abstract][Full Text] [Related]
16. [Central hemodynamics of a new positive inotropic substance, adibendan. Data from a dose-finding study].
Peters P; Saborowski F; May E; Schneider M
Arzneimittelforschung; 1990 Jun; 40(6):666-8. PubMed ID: 2397002
[TBL] [Abstract][Full Text] [Related]
17. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
Petein M; Levine TB; Cohn JN
Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
[TBL] [Abstract][Full Text] [Related]
18. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response.
Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689
[TBL] [Abstract][Full Text] [Related]
19. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
[TBL] [Abstract][Full Text] [Related]
20. Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure.
Shekhar YC; Anand IS; Sarma R; Ferrari R; Wahi PL; Poole-Wilson PA
Am J Cardiol; 1991 Apr; 67(8):732-6. PubMed ID: 2006623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
